QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)

Dolby Laboratories (DLB) SEC Filings & 10K Form

$78.18
-0.11 (-0.14%)
(As of 04:10 PM ET)

Recent Dolby Laboratories SEC Filings

DateFilerForm TypeView
02/28/2024
5:29 PM
Dolby Laboratories (Subject)
Pendleton Todd (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
3:22 PM
Dolby Laboratories (Issuer)
YEAMAN KEVIN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
8:24 PM
Couling John D (Reporting)
Dolby Laboratories (Issuer)
Form 4/A
02/09/2024
4:20 PM
Couling John D (Reporting)
Dolby Laboratories (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/09/2024
3:19 PM
Dolby Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/08/2024
6:38 PM
Dolby Laboratories (Issuer)
Sud Anjali (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
3:37 PM
Dolby Laboratories (Issuer)
GOTCHER PETER C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
3:41 PM
Dolby Laboratories (Issuer)
Prophet Tony A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
3:42 PM
Couling John D (Reporting)
Dolby Laboratories (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/08/2024
3:48 PM
Dolby Laboratories (Issuer)
Rollins Emily (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
9:43 AM
Dolby Laboratories (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G/A
01/24/2024
1:27 PM
BlackRock Inc. (Filed by)
Dolby Laboratories (Subject)
Form SC 13G/A
01/19/2024
3:24 PM
Dolby Laboratories (Issuer)
YEAMAN KEVIN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
3:41 PM
Dolby Laboratories (Subject)
YEAMAN KEVIN J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/22/2023
7:35 AM
Dolby Laboratories (Filer)
Form DEF 14A
12/22/2023
7:37 AM
Dolby Laboratories (Filer)
Form DEFA14A
12/22/2023
7:40 AM
Dolby Laboratories (Filer)
Form ARS
12/19/2023
6:30 PM
Dolby Laboratories (Issuer)
Nicholson Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
6:31 PM
Dolby Laboratories (Issuer)
Revankar Shriram (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
6:31 PM
Dolby Laboratories (Issuer)
Park Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
6:33 PM
Dolby Laboratories (Issuer)
Pendleton Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
6:34 PM
Couling John D (Reporting)
Dolby Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
6:34 PM
Dolby Laboratories (Issuer)
SHERMAN MARK ANDREW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
6:35 PM
Dolby Laboratories (Issuer)
YEAMAN KEVIN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
3:30 PM
Dolby Laboratories (Subject)
SHERMAN MARK ANDREW (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/14/2023
4:58 PM
Dolby Laboratories (Issuer)
YEAMAN KEVIN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
4:24 PM
Dolby Laboratories (Subject)
YEAMAN KEVIN J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
4:01 PM
Dolby Laboratories (Filer)
Form PRE 14A
11/24/2023
3:58 PM
Dolby Laboratories (Issuer)
YEAMAN KEVIN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
8:33 PM
Dolby Laboratories (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
10/19/2023
4:17 PM
Dolby Laboratories (Issuer)
YEAMAN KEVIN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2023
5:08 PM
Dolby Laboratories (Issuer)
Park Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2023
3:17 PM
Dolby Laboratories (Subject)
YEAMAN KEVIN J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/14/2023
6:41 PM
Dolby Laboratories (Issuer)
YEAMAN KEVIN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
4:35 PM
Dolby Laboratories (Subject)
YEAMAN KEVIN J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/31/2023
5:50 PM
Dolby Laboratories (Subject)
Pendleton Todd (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/03/2023
4:26 PM
Dolby Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/14/2023
3:34 PM
Dolby Laboratories (Issuer)
SHERMAN MARK ANDREW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/13/2023
4:26 PM
Dolby Laboratories (Subject)
YEAMAN KEVIN J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/13/2023
3:54 PM
Dolby Laboratories (Issuer)
YEAMAN KEVIN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
3:34 PM
Dolby Laboratories (Subject)
SHERMAN MARK ANDREW (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Will this $2 AI stock double overnight? (Ad)

It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!

Click here to learn more >>>
07/11/2023
3:40 PM
Dolby Laboratories (Subject)
YEAMAN KEVIN J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/15/2023
3:47 PM
Dolby Laboratories (Issuer)
YEAMAN KEVIN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
6:49 PM
Dolby Laboratories (Subject)
YEAMAN KEVIN J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/18/2023
6:25 PM
Dolby Laboratories (Issuer)
Revankar Shriram (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2023
6:27 PM
Dolby Laboratories (Issuer)
YEAMAN KEVIN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2023
4:21 PM
Dolby Laboratories (Subject)
YEAMAN KEVIN J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2023
4:12 PM
Couling John D (Reporting)
Dolby Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2023
2:05 PM
Dolby Laboratories (Subject)
Rollins Emily (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:DLB) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners